e-learning
resources
Milan 2017
Wednesday, 13.09.2017
Monitoring asthma control
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Cluster analysis of severe life-threatening asthma: identification of a distinct phenotype characterized by high serum eosinophils
P. Lau (Singapore, Singapore)
Source:
International Congress 2017 – Monitoring asthma control
Session:
Monitoring asthma control
Session type:
Poster Discussion
Number:
4763
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
P. Lau (Singapore, Singapore). Cluster analysis of severe life-threatening asthma: identification of a distinct phenotype characterized by high serum eosinophils. 4763
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Management of Severe Asthma in Pediatric Patients by an Interdisciplinary Team in a Public Hospital Setting.
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Related content which might interest you:
Two phenothypes of severe asthma identified by cluster analysis
Source: International Congress 2018 – Clinical markers of asthma
Year: 2018
Cluster analysis identifies distinct clinical phenotypes with poor treatment responsiveness in asthma.
Source: International Congress 2018 – Asthma: clinical screening tools
Year: 2018
Characteristics, definition and phenotypes of severe asthma
Source: Eur Respir Mon 2011; 51: 50-58
Year: 2011
Analysis of phenotypes in a group of severe asthma
Source: International Congress 2019 – Immunopathological mechanisms of lung disease
Year: 2019
Increased sputum B cells in severe eosinophilic asthma: a local auto-inflammatory process
Source: International Congress 2018 – Asthma, rhinitis and COPD: cells, mediators, biomarkers and genetics
Year: 2018
Distribution of the cellular inflammatory pattern in induced sputum in an eosinophilic severe asthma population.
Source: International Congress 2019 – Airway diseases and blood cells
Year: 2019
Two novel, severe asthma phenotypes identified during childhood using a clustering approach
Source: Eur Respir J 2012; 40: 55-60
Year: 2012
Defining the clinical clusters of severe asthma within UBIOPRED
Source: International Congress 2015 – Fingerprinting severe asthma
Year: 2015
Cellular inflammatory pattern in induced sputum among patients with stable moderate or severe asthma
Source: Annual Congress 2010 - Biomarkers and Diagnosis of asthma and allergic respiratory diseases
Year: 2010
Cluster analysis and clinical asthma phenotypes
Source: Annual Congress 2013 –Severe asthma: moving from phenotyping to endotyping
Year: 2013
Discriminating phenotypes of severe eosinophilic asthma using gene profiling in sputum
Source: International Congress 2018 – Does asthma phenotyping improve treatment?
Year: 2018
Late Breaking Abstract - Type 2 biomarker expression (FeNO and blood eosinophils) is higher in severe adult-onset than in severe early-onset asthma
Source: Virtual Congress 2021 – Pearls in immunology, outcome studies and clinical trials in asthma, alpha-1 antitrypsin deficiency and COPD
Year: 2021
Identifying adult asthma phenotypes using a clustering approach
Source: Eur Respir J 2011; 38: 310-317
Year: 2011
Study on levels of high sensitivity C reactive protein in asthmatic patients during exacerbation and remission and its correlation with pulmonary function
Source: Annual Congress 2007 - Mechanisms of airway inflammation
Year: 2007
Distinct clinical phenotypes of airways disease defined by cluster analysis
Source: Eur Respir J 2009; 34: 812-818
Year: 2009
Differential mast cell activation by transcriptomic signature analysis in the U-BIOPRED severe asthma cohort
Source: Virtual Congress 2020 – Novel methods, diagnostics and biomarkers of chronic lung diseases
Year: 2020
Airway gene expression identifies subtypes of Type 2 inflammation in severe asthma
Source: Virtual Congress 2020 – Novel molecular markers and targets for asthma phenotypes
Year: 2020
Airway eosinophilia is not related to clinical and functional findings in a large group of severe refractory asthmatics
Source: Annual Congress 2006 - Monitoring airway inflammation – exhaled markers
vs
induced sputum
Year: 2006
Gene expression in CD4+ T-cells reflects heterogeneity in infant wheezing phenotypes
Source: Eur Respir J 2008; 32: 1203-1212
Year: 2008
Concordance in temporally distinct blood and sputum inflammatory phenotypic measures in severe asthma
Source: International Congress 2019 – Clinical implications of asthma management
Year: 2019
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept